• 2020
  Guenin-Macé L, Morel JD, Doisne JM, Schiavo A, Boulet L, Mayau V, Goncalves P, Duchatelet S, Hovnanian A, Bondet V, Duffy D, Ungeheuer MN, Delage M, Nassif A, Di Santo JP, Demangel C, , Dysregulation of tryptophan catabolism at the host-skin microbiota interface in Hidradenitis Suppurativa., 2020 Sep 24;140598..
• 2020
  Delage M, Jais JP, Lam T, Guet-Revillet H, Ungeheuer MN, Consigny PH, Nassif A, Join-Lambert O, , Rifampin-moxifloxacin-metronidazole combination therapy for severe Hurley Stage 1 Hidradenitis Suppurativa: prospective short-term trial and one-year follow-up in 28 consecutive patients., J Am Acad Dermatol 2020 Jan; (): .
• 2018
  19. Loget J, Saint-Martin C, Guillem P, Kanagaratnam L, Becherel PA, Nassif A, Fougerousse AC, Siham M, Girard C, Barthelemy H, Chaby G, Gabison G, Perrot JL, Pallure V, Beneton N, Boye T, Jacobzone C, Begon E, Bernard P, Reguiai Z , Misdiagnosis of hidradenitis suppurativa continues to be a major issue. The R-ENS Verneuil study, Ann Dermatol Venereol. 2018 Apr 25. Pii: S0151-9638(18)30054-1. doi : 10.1016/j.annder. 2018.01.043.
• 2018
  18. Nail-Barthelemy R, Stroumza N, Qassemyar Q, Delage M, Nassif A, Atlan M., Evaluation of the mobility of the shoulder and quality of life after perforator flaps for recalcitrant axillary hidradenitis, Ann Chir Plast Esthet. 2018 Feb 13. pii: S0294-1260(18)30005-0. doi: 10.1016/j.anplas.2018.01.003.
• 2017
  Guet-Revillet H, Jais JP, Ungeheuer MN, Coignard-Biehler H, Duchatelet S, Delage M, Lam T, Hovnanian A, Lortholary O, Nassif X, Nassif A, Join-Lambert O, The Microbiological Landscape of Anaerobic Infections in Hidradenitis Suppurativa: A Prospective Metagenomic Study, Clin. Infect. Dis. 2017 Jul;65(2):282-291.
• 2017
  17. Zouboulis CC, Tzellos T, Kyrgidis A, Jemec GBE, Bechara FG, Giamarellos-Bourboulis EJ, Ingram JR, Kanni T, Karagiannidis I, Martorell A, Matusiak Ł, Pinter A, Prens EP, Presser D, Schneider-Burrus S, von Stebut E, Szepietowski JC, van der Zee HH, Wilden SM, Sabat R, Development and validation of IHS4, a novel dynamic scoring system to assess hidradenitis suppurativa/acne inversa severity, Br J Dermatol. 2017 Jun 21..
• 2017
  Guet-Revillet H, Jais JP, Ungeheuer MN, Coignard-Biehler H, Duchatelet S, Delage M, Lam T, Hovnanian A, Lortholary O, Nassif X, Nassif A, Join-Lambert O, The microbiological landscape of anaerobic infections in Hidradenitis Suppurativa: a prospective metagenomic study., Clin Infect Dis 2017 Apr 1. doi: 10.1093/cid/cix285..
• 2016
  Faivre C, Villani AP, Aubin F, Lipsker D, Bottaro M, Cohen JD, Durupt F, Jeudy G, Sbidian E, Toussirot E, Badot V, Barbarot S, Debarbieux S, Delaporte E, Goegebeur G, Morel J, Nassif A, Duru G, Jullien D , Hidradenitis suppurativa (HS): An unrecognized paradoxical effect of biologic agents (BA) used in chronic inflammatory diseases., J Am Acad Dermatol. 2016 Mar 7. .
• 2016
  Join-Lambert O, Coignard-Biehler H, Jais JP, Delage M, Guet-Revillet H, Poirée S, Duchatelet S, Jullien V, Hovnanian A, Lortholary O, Nassif X, Nassif A., Efficacy of ertapenem in severe Hidradenitis Suppurativa: a pilot study in a cohort of 30 consecutive patients, J Antimicrob Chemother 2016 Feb : 71(2) :513-20.
• 2015
  Join-Lambert O, Duchatelet S, Delage M, Miskinyte S, Coignard H, Lemarchand N, Alemy-Carreau M, Lortholary O, Nassif X, Hovnanian A, Nassif A, Remission of refractory pyoderma gangrenosum, severe acne, and hidradenitis suppurativa (PASH) syndrome using targeted antibiotic therapy in 4 patients, J. Am. Acad. Dermatol. 2015 Nov;73(5 Suppl 1):S66-9.
• 2015
  Delage M, Guet-Revillet H, Duchatelet S, Hovnanian A, Nassif X, Nassif A, Join-Lambert O, Deciphering the microbiology of hidradenitis suppurativa: a step forward towards understanding an enigmatic inflammatory skin disease, Exp. Dermatol. 2015 Oct;24(10):736-7.
• 2014
  Join-Lambert O, Ribadeau-Dumas F, Jullien V, Kitzis MD, Jais JP, Coignard-Biehler H, Guet-Revillet H, Consigny PH, Delage M, Nassif X, Lortholary O, Nassif A., A. Dramatic reduction of clindamycin plasma concentration in hidradenitis suppurativa patients treated with the rifampin-clindamycin combination., Eur J Dermatol. 2014 Jan, 24(1) :94-5.